Functional Fc Gamma Receptor Gene Polymorphisms and Long-Term Kidney Allograft Survival

Area of Science:

• Immunogenetics
• Transplantation immunology
• Renal transplant outcomes

Background:

• Donor-specific HLA antibodies can cause microcirculation inflammation, a key factor in antibody-mediated renal allograft rejection.
• The FCGR3A-V/F158 polymorphism was previously suggested to influence this inflammatory potential.
• Long-term transplant outcomes related to this polymorphism have not been previously evaluated.

Purpose of the Study:

• To investigate the impact of the FCGR3A-V/F158 polymorphism on long-term kidney transplant survival.
• To assess the influence of other Fc gamma receptor (FcγR) functional polymorphisms on transplant outcomes.
• To evaluate outcomes in high-risk patient subgroups.

Main Methods:

• Genotyping of 1,940 recipient/donor pairs for FCGR3A-V/F158 polymorphism.
• Analysis of 10-year death-censored allograft survival.
• Multivariable Cox regression analysis to assess independent survival effects.
• Evaluation of FCGR2A-H/R131 and FCGR3B-NA1/NA2 polymorphisms.

Main Results:

• No significant differences in 10-year death-censored allograft survival were observed in relation to FCGR3A-V/F158 genotype.
• The FCGR3A-V/F158 polymorphism showed no independent survival effect in multivariable analysis.
• Functional polymorphisms in FCGR2A and FCGR3B were also not associated with transplant outcome.
• No significant survival differences were found in high-risk subgroups, including pre-sensitized recipients and those treated for rejection.

Conclusions:

• The FCGR3A-V/F158 polymorphism does not appear to significantly impact long-term kidney transplant survival.
• The association between Fc gamma receptor polymorphism and microcirculation inflammation may not be strong enough to affect graft survival.
• Further research may be needed to understand the complex factors influencing renal allograft rejection and long-term outcomes.